Skip to content
MalariaX
MalariaX platform
VisionBuilding

Blood-film analysis on the microscope a laboratory already owns. Detection, localisation and parasite density, with a qualified reader signing every result.

ForecastPlanned

Transmission-risk estimates built from verified diagnostic counts combined with rainfall, temperature and land use.

GenomeResearch

Drug-resistance marker surveillance. Depends on sequencing partners and an ethics framework we do not yet have.

CommandPlanned

A programme-level view across sites for ministries and malaria control programmes, once enough laboratories are running Vision.

The science
Why microscopy fails

In Dar es Salaam laboratories reported 53% of slides positive where expert re-reading confirmed 2%.

Why it is hard

Stain variation, debris that mimics parasites, five orders of magnitude in density, and no two optical rigs alike.

The workflow

What happens to a slide, from the staining bench through to a signed report with species and density.

Architecture

Where data moves, where it branches back for recapture, and where it stops until a person signs.

Compute stack

The NVIDIA and AWS components running today, and the ones marked planned because they are not.

Validation plan

Four stages from annotation to prospective study. We mark our position on it honestly, which is stage one.

Datasets

The public microscopy data we train on, and a plain statement of what each one cannot tell us.

Safety & oversight

The five places the model is not allowed to decide, written as constraints rather than principles.

Who we build for
Diagnostic laboratories

High slide volume, direct cost pressure from re-reads, and no procurement committee to clear.

Hospital networks

Multi-site groups that need the same slide to produce the same number in every one of their laboratories.

Research groups & trials

Studies that need defensible, auditable density counts and already work to a written protocol.

National programmes

Surveillance built on verified diagnoses. Requires prospective data and a regulatory position first.

Pilot programmeOpen

We are recruiting a small number of laboratories in endemic settings to test on real slides under a research protocol.

Team

The three people building MalariaX, what each of them owns, and where to check their work.

Market & model

Who we would sell to first, who comes only after evidence, and why we will not quote you a confident price yet.

Contact

Four routes to the right person. Pilot sites and parasitologists are answered first, because that is what we are short of.

FAQ

Straight answers, including whether we have results yet and what approval we hold. The answer to both is none.

FAQ Pilot programme Contact us
Vision · buildingForecast · plannedGenome · researchCommand · planned
Why microscopy failsWhy it is hardThe workflowArchitectureCompute stackValidation planDatasetsSafety & oversight
Diagnostic laboratoriesHospital networksResearch groupsNational programmes
TeamMarket & modelContactInvestorsFAQ
Pilot programme Contact us
Legal

Privacy policy

The short version

  • The only personal data this site collects is what you type into the contact form, and only once you have ticked the box next to it.
  • No cookies, no analytics, no tracking pixels, and no mailing list. Writing to us does not sign you up to anything.
  • No patient data and no clinical images pass through this website. Section 08 sets out where those actually live.
  • Anything on this page can be settled by writing to hello@malariax.com.

This summary is here to be useful, not to be relied on. The numbered sections below are the policy.

What the contact form collects What happens when you browse Why we process it Who else sees it How long we keep it How it is protected Your rights Blood films and patient data Changes, and how to reach us

What the contact form collects

One thing on this site asks you for anything, and that is the contact form. It collects six fields, four of which are required:

  • Full name and work email — so a reply goes to a person, at an address that works
  • What is this about — the topic you pick, which decides who reads it
  • Message — whatever you choose to write
  • Organisation and country — both optional, and useful mainly for working out whether a pilot is even practical

The form will not send until you tick the box that reads “I am happy for MalariaX to store these details in order to reply. We do not add anyone to a mailing list.” That sentence is the whole of what we are asking permission for, and we hold ourselves to the second half of it.

There are no hidden fields. Nothing is appended behind the form — no device fingerprint, no referrer, no marketing identifier, and no lookup of your email address against a third-party database to find out who you are.

Depending on how the form is configured it either posts to our own endpoint, or opens a message in your email client already filled in and addressed by topic — pilot enquiries, research and advisory, investment, or general. In that second case the message passes through your own organisation’s mail system before it reaches us, under their rules rather than ours, and you can edit or abandon it before it sends.

What happens when you browse

Nothing is stored on your device

This site sets no cookies and writes nothing to local storage. It carries no analytics, no heatmap, no session recording and no advertising script. There is no consent banner because there is nothing to consent to. That describes the site as it stands on the date at the top of this page; if it ever changes, this policy changes with it and that date moves.

Server logs

Our hosting provider keeps ordinary web server logs: IP address, timestamp, the file requested, the response code, and the user-agent string your browser sends. Those are a by-product of serving a page at all, and we use them to keep the site up and to look into faults or abuse.

Typefaces

Three typefaces load from fonts.googleapis.com and fonts.gstatic.com. Your browser fetches them directly, which tells Google your IP address and user-agent under Google’s own terms. Nothing comes back to us and we cannot see who asked for what. A content blocker will stop the request, and the page falls back to the fonts already on your machine without breaking.

Links out

This site links to a fair amount of other people’s work — the World Health Organization, published papers, public image datasets. Following one takes you somewhere with its own policy, and this one stops applying the moment you leave.

Why we process it, and on what basis

  • To answer you. You filled in a form asking us to get in touch, and ticked a box saying so. Basis: your consent, plus steps taken at your request.
  • To work out whether a pilot or a collaboration is possible. If a message turns into a real conversation, the same details carry it, and later the agreement covering it. Basis: steps taken before entering into a contract.
  • To keep the site running. Server logs, for faults and abuse. Basis: our legitimate interest in a site that works and is not under attack.

Consent given by ticking a box can be withdrawn by saying so, and withdrawing it costs you nothing. We do no profiling and no automated decision-making about you. We do not sell, rent or trade anything collected here, and there is no mailing list to be added to — not as a matter of policy, but because one does not exist.

Who else sees it

What you send through this site reaches:

  • Our hosting and email providers, which handle it in the course of serving the page and delivering the message
  • The form endpoint, where the form is configured to post to a third-party form service rather than to our own infrastructure
  • Professional advisers, on the occasions we need advice on something
  • A public authority, where the law requires it and we are satisfied that it does

Each of those acts on our instructions under a written agreement and cannot use your details for its own ends. Nothing goes to an advertising network or a data broker, since we use neither.

How long we keep it

  • An enquiry that goes nowhere: deleted within 24 months of the last exchange.
  • Correspondence that becomes a collaboration: kept for as long as the work runs, and afterwards for as long as the relevant limitation period requires.
  • Server logs: whatever the hosting provider’s ordinary cycle is, typically no more than 90 days.

If you want something gone sooner than that, ask and it will be.

How it is protected

The site is served over HTTPS, and access to anything submitted through it is authenticated and limited to the people who need to read it. We are a small team, which makes that easier to enforce than it would be at scale, and also means there is nobody to hide behind if we get it wrong.

What we will not do is describe our security in terms designed to sound more thorough than it is. If you are evaluating us as a data partner, ask, and you will get a specific answer rather than an adjective.

Your rights

Whatever law applies where you are, you can expect to be told how your data is used, to get a copy of it, to have it corrected if it is wrong, to have it deleted, to object to us processing it, and to withdraw a consent you have given. Where the GDPR or UK GDPR reaches you, the rights to restrict processing and to data portability apply as well.

Exercise any of them by writing to hello@malariax.com. We will not charge you, and we will not ask you to justify the request.

If we handle it badly, you can take it to the data protection authority for your country. We would rather you came to us first, but nothing obliges you to.

Blood films, patient data and research images

No patient data reaches this website. There is no portal here, nothing to upload, and no clinical system behind it. If you are a patient who has had a malaria test, nothing about that test is on this site or in anything it connects to.

The research itself is a separate matter. Blood-film images used to develop and test our models come from laboratories, public datasets and research partners, under data-sharing agreements and the ethics approvals that go with them. Those agreements set what may be transferred, how it is de-identified before it leaves the laboratory, what it may be used for, and when it must be destroyed. They govern that work — this page does not, and cannot vary them.

Where an image originates with a patient, the relationship is with the institution that collected it. That institution decides what happens to it, and a request about it has to go there rather than to us. Tell us and we will pass it on, but we cannot act on it directly.

The photographs, illustrations and the overview film on this site are illustrative. None of them is patient material, and none of them is a real specimen or a real product output.

Changes, and how to reach us

When this policy changes, the date and version at the top of the page change with it. Where a change materially affects details you have already given us, we will write to you about it rather than leave you to notice.

Questions about this policy, or about anything else on this site: hello@malariax.com.

MalariaX

Pre-clinical research on parasite quantification in malaria microscopy.

Platform
Overview filmVisionForecastGenomeCommand
Science
The problemArchitectureValidationDatasetsSafety
Company
TeamMarketContactFAQSources
© 2026 MalariaX · Research stage, no regulatory clearance All figures cited · Privacy · Back to top